Literature DB >> 1078713

Clinical importance of lymphoblasts with T markers in childhood acute leukemia.

L Sen, L Borella.   

Abstract

Of 48 children with acute lymphocytic leukemia 11 had blast cells with receptors for sheep erythrocytes in their initial bone-marrow aspirates and 37 did not. A comparison of selected clinical features indicated striking differences between the two groups. Leukemia with the receptors was associated with a high proportion of older children, predominantly boys, a thymic mass, and a high white-cell count at diagnosis. In contrast, the 37 children with leukemia without the receptors were generally less than five years of age, with a nearly equal distribution of boys and girls; all but one had normal chest roentgenograms, and only one had a white-cell count greater than 100,000. Thus, the presence or absence of lymphoblasts with sheep erythrocyte receptors--a T-cell marker--distinguishes two forms of childhood acute lymphocytic leukemia, each with a distinct distribution of age and sex as well as other characteristic clinical features.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1078713     DOI: 10.1056/NEJM197504172921604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  41 in total

1.  T and B lymphocytes in humans. A review.

Authors:  J H Kersey; J Gajl-Peczalska
Journal:  Am J Pathol       Date:  1975-11       Impact factor: 4.307

2.  Childhood leukemia and neonatal exposure to lighting in nurseries.

Authors:  R W Miller
Journal:  Cancer Causes Control       Date:  1992-11       Impact factor: 2.506

3.  Use of stimulating capacity of mixed lymphocyte reaction (MLR-S) as a possible marker for the cell-origin of null-cell acute lymphoblastic leukaemia.

Authors:  T Han; J Minowada
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

4.  Synergistic activity of rapamycin and dexamethasone in vitro and in vivo in acute lymphoblastic leukemia via cell-cycle arrest and apoptosis.

Authors:  Chong Zhang; Yong-Ku Ryu; Taylor Z Chen; Connor P Hall; Daniel R Webster; Min H Kang
Journal:  Leuk Res       Date:  2011-12-03       Impact factor: 3.156

5.  Surface markers in leukemias and lymphomas.

Authors:  F P Siegal; D A Filippa; B Koziner
Journal:  Am J Pathol       Date:  1978-02       Impact factor: 4.307

6.  Immunological characteristics of lymphoblasts and lymphocytes in acute lymphoblastic leukaemia in children.

Authors:  D Olive; D Sabolovic; M C Beugnot; M Beaugnon
Journal:  Clin Exp Immunol       Date:  1977-08       Impact factor: 4.330

7.  A human thymus-leukemia antigen defined by hybridoma monoclonal antibodies.

Authors:  R Levy; J Dilley; R I Fox; R Warnke
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

8.  Subset derivation of T-cell acute lymphoblastic leukemia in man.

Authors:  E L Reinherz; L M Nadler; S E Sallan; S F Schlossman
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

9.  The immunological classification of leukaemia based on a rapid microcytotoxicity test.

Authors:  R J Billing; K A Foon; M Linker-Israeli
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

10.  Malignant lymphomas: cell surface markers and advances in classification.

Authors:  J A Strauchen
Journal:  West J Med       Date:  1981-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.